The first stethoscope was introduced in the market in 1818 by a French physician René Laennec. Since then, there have been huge advancements in the field of cardiac imaging and radiology.
The first stethoscope was introduced in the market in 1818 by a French physician René Laennec. Since then, there have been huge advancements in the field of cardiac imaging and radiology. Cardiovascular diseases are still the major cause of death in the world, and early diagnosis is quintessential to save lives.
Read Report Overview - https://www.transparencymarketresearch.com/smart-stethoscopes-market.html
A vast number of noninvasive investigational modalities exist for early diagnosis of cardiac disorders, such as cardiac computed tomographic (CT) scan, electrocardiography, echocardiography, and cardiac magnetic resonance imaging, which have diminished the use of conventional stethoscope in modern times.
However, the major limitations with these advancements are the need of trained personnel for investigation and interpretation of results. The other significant limitations are their cost and availability only in advanced centers. Compared to this, stethoscope is relatively cost effective, easy to use, and easily available that can be used by paramedics and nurses. In developing country like India, where penetration of advanced medical imaging in rural areas is low, stethoscope plays important role in diagnosis of cardiac and pulmonary disorders. Smart or digital stethoscopes offer a new perspective over the conventional stethoscope and hence it would be a useful tool in armamentarium of healthcare professionals.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=68117
Smart Stethoscopes Market – Competitive Landscape
The global smart stethoscopes market comprises large and mid-size vendors. Key players in smart stethoscopes market include Thinklabs Medical LLC, 3M, HD Medical Group, Welch Allyn, Clinicloud Inc, American Diagnostic Corporation, eKuore and Cardionics. These companies are making efforts to expand their presence in developing and underdeveloped countries through collaboration with various suppliers.
Welch Allyn, Inc.
Founded in 1915, Welch Allyn, Inc. is a U.S.-based global medical device company, engaged in the manufacture of medical diagnostic equipment. The company markets its products in over 50 countries globally through an established sales and distribution network. It offers products in areas of vital signs monitoring, patient monitoring, diagnostic cardiopulmonary, blood pressure measurement, physical assessment, thermometry, cardiopulmonary, population health management technologies, and software and services. Headquartered in New York, the U.S., Welch Allyn, Inc. principally operates in North America, Asia Pacific, Europe, the Middle East, and Latin America.
Request for Analysis of COVID-19 Impact on Smart Stethoscopes Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=68117
3M
3M is a leading global player in the field of technology innovation. It manufactures and markets diverse products and services worldwide. It primarily operates through five business segments: healthcare, industrial, safety and graphics, electronics and energy, and consumer. The company’s healthcare segment caters to various markets including medical clinics and hospitals, pharmaceuticals, dental and orthodontic practitioners, health information systems, and food manufacturing and testing. 3M has corporate operations in 70 nations and customers spread across 200 countries worldwide.
New Perspective over Conventional Stethoscope is likely to drive the Smart Stethoscopes Market
The smart stethoscope is a user friendly and cost efficient equipment that help physicians to arrive at accurate results. Smart stethoscopes are now emerging as a new homecare medical device and an effective assistant for doctors. These stethoscopes aid in diagnosis of respiratory diseases and disorders based on heart rate. The conventional stethoscope since have been playing a very important role in the department of cardiology until now. However, nowadays there is huge demand to replace the conventional stethoscopes with advanced versions. There are some drawbacks associated with conventional stethoscopes such as low sound quality, especially in obese patients and patients with thick chest wall. There is complete abolition of sound transmission in case of cardiac murmurs. The electronic stethoscope contains a large chest piece with a battery case below it which contains the LED display showing volume control, battery status, heart rate and a control mode to choose between bell, diaphragm, and extended mode.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=68117
High Adoption of Technologically Advanced Products and Expanding Healthcare Infrastructure is likely to drive the Smart Stethoscopes Market
Globally, North America is expected to account for the highest share of the smart stethoscopes market in terms of revenue followed by Europe. These two regions are expected to retain their leadership positions throughout the forecast period. The superiority of these two regions is majorly due to well-developed healthcare infrastructure, presence of major players operating in medical devices, high adoption of technologically advanced products and high disposable income. Moreover, high incidence and prevalence of cardiac and pulmonary disorders has further fuelled the smart stethoscopes market in the region. According to the Centers for Disease Control and Prevention (CDC), one in every four deaths in North America is caused due to heart disease. China and India are the major markets in Asia Pacific that offer large opportunities for the smart stethoscopes market. The smart stethoscopes market in Asia Pacific is projected to expand at the highest CAGR compared to other regions.
Pre Book Smart Stethoscopes Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=68117<ype=S
Cardiovascular disease is among the top five causes of death in Asia and is characterized by large unmet needs that provide ample growth opportunities for the players in the region. Expanding health care infrastructure, rising disposable income, large obese and geriatric populations are some of the factors that are expected to play a key role in making Asia Pacific the most attractive market for manufacturers operating in the region.
Browse More Trending Reports by Transparency Market Research:
Acne Drugs Market: https://www.transparencymarketresearch.com/acne-drugs-market.html
Human Recombinant Insulin Market: https://www.transparencymarketresearch.com/human-recombinant-insulin-market.html
Diabetic Nephropathy Market: https://www.transparencymarketresearch.com/diabetic-nephropathy-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/